Cargando…
A Sensitive Whole Blood Assay Detects Antigen-Stimulated Cytokine Release From CD4+ T Cells and Facilitates Immunomonitoring in a Phase 2 Clinical Trial of Nexvax2 in Coeliac Disease
Improved blood tests assessing the functional status of rare gluten-specific CD4+ T cells are needed to effectively monitor experimental therapies for coeliac disease (CD). Our aim was to develop a simple, but highly sensitive cytokine release assay (CRA) for gluten-specific CD4+ T cells that did no...
Autores principales: | Hardy, Melinda Y., Goel, Gautam, Russell, Amy K., Chen Yi Mei, Swee Lin G., Brown, Gregor J. E., Wang, Suyue, Szymczak, Evan, Zhang, Ruan, Goldstein, Kaela E., Neff, Kristin M., Williams, Leslie J., Truitt, Kenneth E., Dzuris, John L., Tye-Din, Jason A., Anderson, Robert P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171185/ https://www.ncbi.nlm.nih.gov/pubmed/34093551 http://dx.doi.org/10.3389/fimmu.2021.661622 |
Ejemplares similares
-
Patient factors influencing acute gluten reactions and cytokine release in treated coeliac disease
por: Tye-Din, Jason A., et al.
Publicado: (2020) -
Coeliac disease: a unique model for investigating broken tolerance in autoimmunity
por: Hardy, Melinda Y, et al.
Publicado: (2016) -
Epitope-Specific Immunotherapy Targeting CD4-Positive T Cells in Celiac Disease: Safety, Pharmacokinetics, and Effects on Intestinal Histology and Plasma Cytokines with Escalating Dose Regimens of Nexvax2 in a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study
por: Daveson, A. James M., et al.
Publicado: (2017) -
Review article: Follow‐up of coeliac disease
por: Tye‐Din, J. A.
Publicado: (2022) -
Development of the automated immunomonitoring system
por: Osawa, Ryuji, et al.
Publicado: (2014)